4-methyl-1-phenyl-1,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one, 95.0%, 1g

3-[(piperidin-3-yloxy)methyl]pyridine, 95.0%, 5g

2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide, 97.0%, 250mg

Recipiente de transporte Dewar Tipo B (funda metálica, azul), 29 B, 4 l, 138 mm, 1 Pieza

2-((Methoxycarbonyl)amino)acetic acid, 95.0%, 1g

(3aR,6R,6aR)-2,2-Dimethyl-6-vinyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 500mg

7-Chloroquinazolin-4-ol, 95.0%, 5g

(4aR,9aS)-4,4a,9,9a-Tetrahydroindeno[2,1-b][1,4]oxazin-3(2H)-one, 97%, 250mg

4-(2-Hydrazinylethyl)morpholine, 95.0%, 10g

N-(5-Fluoro-2-methylphenyl)-4-methylbenzenesulfonamide, 97%, 250mg

Ethyl 1-cyanocyclopropanecarboxylate, 97.0%, 1g

1,3-Diiodoazulene, 98%, 250mg

Ethyl 5-amino-4-phenylisoxazole-3-carboxylate, 97%, 250mg